These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2728756)

  • 21. [Chronologic study of signs of myocardiopathy in progressive muscular dystrophy].
    Barona Zamora P; Narbona García J; Alvarez Gómez MJ; Fidalgo Andrés ML; Sáenz de Buruaga J; Villa Elizaga I
    An Esp Pediatr; 1993 Feb; 38(2):173-7. PubMed ID: 8439105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approach to diagnosis in the child with muscle weakness.
    Spiro AJ
    Pediatr Ann; 1977 Mar; 6(3):149-61. PubMed ID: 322047
    [No Abstract]   [Full Text] [Related]  

  • 23. [Interview - muscular dystrophies - worldwide search for patients].
    Walter M
    Z Orthop Unfall; 2011 Aug; 149(4):365-7. PubMed ID: 21845546
    [No Abstract]   [Full Text] [Related]  

  • 24. [Gene deletion analysis in molecular diagnosis of Duchenne-Becker muscular dystrophy].
    Endreffy E; László A; Kálmán M; Krenács T; Raskó I
    Orv Hetil; 1994 Feb; 135(8):399-403. PubMed ID: 8139842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A; Sluga E; Moser K
    Wien Klin Wochenschr; 1971 Feb; 83(7):109-13. PubMed ID: 5547427
    [No Abstract]   [Full Text] [Related]  

  • 26. Congenital muscular dystrophy with rigid spine syndrome: a clinical, pathological, radiological, and genetic study.
    Flanigan KM; Kerr L; Bromberg MB; Leonard C; Tsuruda J; Zhang P; Gonzalez-Gomez I; Cohn R; Campbell KP; Leppert M
    Ann Neurol; 2000 Feb; 47(2):152-61. PubMed ID: 10665485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of satellite potentials in clinical EMG.
    Rowińska-Marcińska K; Ryniewicz B; Hausmanowa-Petrusewicz I; Karwańska A
    Electromyogr Clin Neurophysiol; 1997; 37(8):483-9. PubMed ID: 9444488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Polymyositides imitating progressive muscular dystrophy of the Duchenne type].
    Rozhold O; Hamalová J
    Fysiatr Revmatol Vestn; 1978 Oct; 56(5):264-9. PubMed ID: 568108
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic indications in scoliosis of Duchenne muscular dystrophy. Apropos of 10 cases].
    Rideau Y
    Rev Chir Orthop Reparatrice Appar Mot; 1984; 70(7):567-76. PubMed ID: 6240091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognosis of progressive muscular dystrophy in children. Analysis of early and exact criteria].
    Rideau Y
    Union Med Can; 1977 Jun; 106(6):874-82. PubMed ID: 883053
    [No Abstract]   [Full Text] [Related]  

  • 31. [Muscular magnetic resonance imaging for evaluation of myopathies in children].
    Peters SA; Köhler C; Schara U; Hohendahl J; Vorgerd M; Nicolas V; Heyer CM
    Klin Padiatr; 2008; 220(1):37-46. PubMed ID: 18098096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of Duchenne muscular dystrophy: parents' experiences and satisfaction.
    Green JM; Murton FE
    Child Care Health Dev; 1996 Mar; 22(2):113-28. PubMed ID: 8820016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [NMR-CT in muscular disorders--muscle T1 values in normal children and Duchenne muscular dystrophy patients].
    Matsumura K; Nakano I; Ikehira H; Fukuda N; Tateno Y; Aoki Y; Kawai M
    Rinsho Shinkeigaku; 1986 Jul; 26(7):733-41. PubMed ID: 3769321
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiac problems in patients with progressive muscular dystrophy].
    Danzig V; Fiksa J; Hani AB; Havlová M; Sonka K
    Sb Lek; 2003; 104(3):273-8. PubMed ID: 15224533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Congenital muscular dystrophy with laminin-a2 deficiency in early infancy: diagnosis and long-term follow-up].
    Panteliadis C; Karatza E; Xinias I; Flaris N; Tzitiridou M; Ramantani G
    Klin Padiatr; 2005; 217(5):281-5. PubMed ID: 16167276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duchenne-type dystrophy: selective aspects of diagnosis and management.
    Preswick G
    Proc Aust Assoc Neurol; 1966; 4():15-9. PubMed ID: 5966200
    [No Abstract]   [Full Text] [Related]  

  • 37. [Muscular dystrophy due to a deficit of gamma-sarcoglycan. A report of three patients with the Delta-521t mutation].
    Eirís-Puñal J; Pintos-Martínez E; Lasa A; Gallano P; Castro-Gago M
    Rev Neurol; 2002 Mar 1-15; 34(5):486-9. PubMed ID: 12040521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy.
    Scott OM; Hyde SA; Goddard C; Dubowitz V
    Muscle Nerve; 1982 Apr; 5(4):291-301. PubMed ID: 7099196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New techniques in diagnosis, assessment of progression and research in muscular dystrophy.
    Stern L
    Aust Paediatr J; 1988; 24 Suppl 1():34-6. PubMed ID: 3060070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in the paediatric population.
    Suresh S; Wales P; Dakin C; Harris MA; Cooper DG
    J Paediatr Child Health; 2005; 41(9-10):500-3. PubMed ID: 16150067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.